Hematology NewsAvapritinib yields high response rate in patients with systemic mastocytosisDecember 10, 2017Myelodysplastic SyndromeMantle Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA grants drug orphan designation for AML, MDSNovember 30, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesRigosertib produces better OS in MDS than tAMLNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesGeneric azacitidine approved in CanadaNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
Hematology NewsFDA approves first Erdheim-Chester disease treatmentNovember 6, 2017Myelodysplastic SyndromeRare DiseasesLeukemia, Myelodysplasia, Transplantation
Hematology TimesDrug receives fast track designation for lower-risk MDSNovember 2, 2017AnemiaMyelodysplastic Syndrome
Hematology TimesATLG fights GVHD but reduces PFS, OSOctober 26, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Hematology TimesDrug receives orphan designation for treatment of MDSOctober 8, 2017AnemiaMyelodysplastic Syndrome
Hematology TimesMutations impact outcomes in AML, MDSSeptember 27, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesFDA grants RMAT designation to HSCT adjunctSeptember 21, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Hematology TimesAntibody shows early promise in AML/MDS trialSeptember 20, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesCHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Hematology TimesVSTs can treat 5 different viral infections after HSCTAugust 14, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Hematology NewsVemurafenib granted sNDA, priority review for Erdheim-Chester diseaseAugust 7, 2017Myelodysplastic Syndrome
Hematology TimesPredicting response to treatment in AML, MDSJuly 26, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
